Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.525    0.00 (0.00%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £2.38m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Physiomics Optimistic On Virtual Tumour Platform Interest

Wed, 12th Nov 2014 10:47

LONDON (Alliance News) - Physiomics PLC Wednesday said that interest in its Virtual Tumour platform "suggest that the next period will be an exciting one in the development of Physiomics", as it posted a slightly narrowed loss in its year to end-June.

The company posted a pretax loss of GBP464,252, narrowed slightly from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.

Physiomics is working on commercialising what it considers its tent-pole product, the Virtual Tumour Clinical platform, a technology that uses a mathematical model to predict the growth of tumours.

During the period the company saw a "large degree" of interest from customers and potential customers for the service, it said. Physiomics noted that the product can be used to design a clinical study, and given the "high cost and subsequent consequences arising from a failed clinical trial", if it can show that its predictive technology can improve the chances of a success, customers are "likely to progressively adopt the new paradigm".

During the period Physiomics delivered two case studies validating the platform, and won further pre-clinical projects from its existing larger pharmaceutical company customer base.

It has continued discussions with partners about increasing the scope of its business via merger or acquisition, and began discussions with an undisclosed software provider to determine if part or all of Virtual Tumour could be sold as part of their offering.

Following the year end the company won a large pharma project to model immunomodulatory agents using Virtual Tumour, which it believes if successful will lead to further interest in the platform.

"Interest from large software providers in the Virtual Tumour platform, the launch of our first web-based models and the continued search for the right M&A deal suggest that the next period will be an exciting one in the development of Physiomics," the company said in a statement.

Shares in Physiomics are trading down 9.3% at 0.136 pence Wednesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

Related News

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down
27 May 2026

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EARNINGS AND TRADING: Supersearch Plus launches drone delivery service
15 May 2026

EARNINGS AND TRADING: Supersearch Plus launches drone delivery service

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

TRADING UPDATES: Barratt Redrow completes second tranche of buyback
8 May 2026

TRADING UPDATES: Barratt Redrow completes second tranche of buyback

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Friday and not separately reported by Alliance ...

Physiomics News

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down
27 May 2026

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EARNINGS AND TRADING: Supersearch Plus launches drone delivery service
15 May 2026

EARNINGS AND TRADING: Supersearch Plus launches drone delivery service

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

TRADING UPDATES: Barratt Redrow completes second tranche of buyback
8 May 2026

TRADING UPDATES: Barratt Redrow completes second tranche of buyback

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Friday and not separately reported by Alliance ...

New Physiomics board launches wide-ranging company review
8 May 2026

New Physiomics board launches wide-ranging company review

(Sharecast News) - Physiomics said on Friday that its newly-appointed board had started a wide-ranging review of the business focused on operational o...

WINNERS & LOSERS: Altona snaps share price fall; Colefax profit climbs
8 May 2026

WINNERS & LOSERS: Altona snaps share price fall; Colefax profit climbs

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

Physiomics stock rises as shareholders vote to oust board
29 Apr 2026

Physiomics stock rises as shareholders vote to oust board

(Alliance News) - Physiomics PLC on Wednesday announced that shareholders at its general meeting agreed to replace the board.

LONDON MARKET MIDDAY: FTSE falls as blue chips weigh on market
29 Apr 2026

LONDON MARKET MIDDAY: FTSE falls as blue chips weigh on market

(Alliance News) - Stock prices in London extended losses by midday Wednesday, as weakness among blue chips outweighed strength in smaller caps.